BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

BioTech Health X

450 posts

Biotech NewsMEI Pharma (MEIP) Shocks Wall Street With $100M Litecoin Bet

  • BioTech Health X
  • August 27, 2025
MEI Pharma Inc. (NASDAQ:MEIP) is a San Diego-based clinical-stage pharmaceutical company that has built its identity around the…
0 Shares
0
0
0
0
0
0
0

Biotech NewsStoke Therapeutics (STOK) Soars but Hidden Risks Could Trigger a Sell-Off

  • BioTech Health X
  • August 27, 2025
Stoke Therapeutics Inc. (NASDAQ:STOK)is a clinical-stage biopharmaceutical company founded in 2014 and headquartered in Bedford, Massachusetts, with a…
0 Shares
0
0
0
0
0
0
0

Biotech NewsGeneration Bio (GBIO) Has $185M in Cash—Here’s Why That Matters

  • BioTech Health X
  • August 26, 2025
Generation Bio Co. (NASDAQ:GBIO) is a biotechnology company pioneering a new class of genetic medicines designed to expand…
0 Shares
0
0
0
0
0
0
0

Biotech NewsRadiopharm (RADX) Stock: High Risk, High Hype

  • BioTech Health X
  • August 26, 2025
Radiopharm Theranostics Ltd. (NASDAQ:RADX) is a clinical-stage biotechnology company focused on the development and commercialization of radiopharmaceutical products…
0 Shares
0
0
0
0
0
0
0

Biotech NewsSalarius Pharmaceuticals (SLRX) Merger Won’t Save it From Trouble

  • BioTech Health X
  • August 26, 2025
Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) is a clinical-stage biopharmaceutical company incorporated in Delaware and headquartered in Houston, Texas. The…
0 Shares
0
0
0
0
0
0
0

Biotech NewsTitan Pharmaceuticals (TTNP) Merger Hype vs. Reality

  • BioTech Health X
  • August 26, 2025
Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) is a biopharmaceutical company that has spent decades focused on the development and commercialization…
0 Shares
0
0
0
0
0
0
0

Biotech NewsHCA Healthcare (HCA) Surges Over 228% Since 2019

  • BioTech Health X
  • August 26, 2025
HCA Healthcare Inc. (NYSE:HCA) is one of the largest healthcare providers in the United States and a leading…
0 Shares
0
0
0
0
0
0
0

Biotech NewsBriaCell (BCTX) Might Be Wall Street’s Best-Kept Biotech Secret

  • BioTech Health X
  • August 26, 2025
BriaCell Therapeutics Corp. (NASDAQ:BCTX) is a clinical-stage biotechnology company committed to developing novel immunotherapies designed to transform cancer…
0 Shares
0
0
0
0
0
0
0

Biotech NewsSummit Therapeutics (SMMT)’s Ivonescimab Shows Global Success—Analysts See Billions Ahead

  • BioTech Health X
  • August 26, 2025
Summit Therapeutics Inc. (NASDAQ:SMMT) is a clinical-stage biopharmaceutical company that has steadily carved out its position as one…
0 Shares
0
0
0
0
0
0
0

Biotech NewsSaudi Arabia Wants CEL-SCI (CVM)’s Multikine Now!

  • BioTech Health X
  • August 26, 2025
CEL-SCI Corporation (NYSE:CVM) is a biotechnology company that has built its identity on innovation, persistence, and the pursuit…
0 Shares
0
0
0
0
0
0
0

Biotech NewsIs CVS Health (CVS) Still a Buy After Years of Legal Battles & Store Closures?

  • BioTech Health X
  • August 25, 2025
CVS Health Corporation (NYSE:CVS) is one of the largest healthcare companies in the United States, operating a unique…
0 Shares
0
0
0
0
0
0
0

Biotech NewsModerna (MRNA) Crashes 90% From Highs

  • BioTech Health X
  • August 25, 2025
Moderna Inc. (NASDAQ:MRNA) is a biotechnology company that rose to global prominence during the COVID-19 pandemic as one…
0 Shares
0
0
0
0
0
0
0

Biotech NewsSerina (SER)’s Parkinson’s Drug Gets FDA Support—Stock Investors Go Wild

  • BioTech Health X
  • August 25, 2025
Serina Therapeutics Inc. (NYSE:SER) is a clinical-stage biotechnology company dedicated to developing transformative therapies for neurological disorders, cancer,…
0 Shares
0
0
0
0
0
0
0

Biotech NewsHCW Biologics (HCWB) Explodes Nearly 100% After Breakthrough News

  • BioTech Health X
  • August 25, 2025
HCW Biologics Inc. (NASDAQ:HCWB) is a clinical-stage biopharmaceutical company founded with the mission of developing novel immunotherapies to…
0 Shares
0
0
0
0
0
0
0

Biotech NewsEvoke Pharma (EVOK) Faces Harsh Reality—Can it Avoid Collapse?

  • BioTech Health X
  • August 24, 2025
Evoke Pharma Inc. (NASDAQ:EVOK) is a specialty pharmaceutical company based in Solana Beach, California, dedicated to developing and…
0 Shares
0
0
0
0
0
0
0

Biotech NewsBBIO Stock Alert: Can BridgeBio Pharma Survive Its Cash Burn?

  • BioTech Health X
  • August 24, 2025
BridgeBio Pharma Inc. (NASDAQ:BBIO) is a commercial-stage biopharmaceutical company founded with the mission of identifying, developing, and delivering…
0 Shares
0
0
0
0
0
0
0

Biotech NewsKala Pharma (KALA) Faces Make-or-Break 2025—Will It Survive?

  • BioTech Health X
  • August 24, 2025
Kala Pharmaceuticals Inc. (NASDAQ:KALA) is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapies for rare…
0 Shares
0
0
0
0
0
0
0
Breakthrough in Alzheimers Treatment Biogen and Eisais Leqembi Wins UK Approval

Biotech NewsEdgewise Therapeutics (EWTX) Warning: Is This Headed for a Collapse?

  • BioTech Health X
  • August 24, 2025
Edgewise Therapeutics Inc. (NASDAQ: EWTX) is a clinical-stage biopharmaceutical company headquartered in Boulder, Colorado, dedicated to developing innovative…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Insmed (INSM) Jumps to $149.20 High After FDA Approval of Brinsupri
  • Ocular Therapeutix (OCUL) Raises $475M to Fund Phase 3 Axpaxli Trials
  • Novavax (NVAX) Expands $200M Sanofi Deal With Matrix-M Adjuvant
  • Recursion Pharmaceuticals (RXRX) Could Double With $8 Price Target
  • Dermata (DRMA) Wins Australian Patent for Acne Therapy
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • October 3, 2025
    Insmed (INSM) Jumps to $149.20 High After FDA Approval of Brinsupri
    • October 3, 2025
    Ocular Therapeutix (OCUL) Raises $475M to Fund Phase 3 Axpaxli Trials
    • October 3, 2025
    Novavax (NVAX) Expands $200M Sanofi Deal With Matrix-M Adjuvant
    • October 3, 2025
    Recursion Pharmaceuticals (RXRX) Could Double With $8 Price Target
    • October 2, 2025
    Dermata (DRMA) Wins Australian Patent for Acne Therapy
Recent Posts
  • Kazia (KZIA) Trades Under $1 While Tackling Cancers With <1-Year Survival Rates
    • October 2, 2025
  • CorMedix (CRMD) Revenue to Hit $350M After Melinta Buyout
    • October 2, 2025
  • Halozyme (HALO) Reports $1.179B Revenue and 65% Royalty Growth
    • October 2, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (439)
  • Uncategorized (1)
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top